Evidence map›Paper›PMID 40355455›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates.

Tanya Tran, Brian P Keane, Judy L Thompson, Ben Robinson, Joshua Kenney, Trevor F Williams, James A Waltz, Jason A Levin, Eren Kafadar, James M Gold and 10 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tanya TranDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA. tanya_tran@urmc.rochester.edu.ORCID http://orcid.org/0000-0002-6303-8394
Brian P KeaneDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Judy L ThompsonDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Ben RobinsonDepartment of Psychiatry, University of Maryland School of Medicine, Catonsville, MD, USA.
Joshua KenneyDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Trevor F WilliamsDepartment of Psychiatry, Northwestern University, Evanston, IL, USA.
James A WaltzDepartment of Psychiatry, University of Maryland School of Medicine, Catonsville, MD, USA.ORCID http://orcid.org/0000-0002-9236-3719
Jason A LevinDepartment of Psychology, University of Georgia, Athens, GA, USA.ORCID http://orcid.org/0000-0002-9123-0404
Eren KafadarDepartment of Psychiatry, Yale University, New Haven, CT, USA.
James M GoldDepartment of Psychiatry, University of Maryland School of Medicine, Catonsville, MD, USA.
Jason SchiffmanDepartment of Psychological Science, University of California, Irvine, CA, USA.
Lauren M EllmanDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA, USA.
Elaine F WalkerDepartment of Psychology and Program in Neuroscience, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-9798-8101
Gregory P StraussDepartment of Psychology, University of Georgia, Athens, GA, USA.
Vijay A MittalDepartment of Psychiatry, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0001-9017-5119
Richard E ZinbargDepartment of Psychiatry, Northwestern University, Evanston, IL, USA.
Philip R CorlettDepartment of Psychiatry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-5368-1992
Albert R PowersDepartment of Psychiatry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3057-5043
Scott W WoodsDepartment of Psychiatry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3103-5228
Steven M SilversteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0002-0699-0960

Funding

2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
5/5 CAPER: Computerized Assessment of Psychosis RiskR01MH120089 · NIMH · YALE UNIVERSITY · PI CORLETT, PHILIP, WOODS, SCOTT W · 2020 to 2024
$3.1M
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation StudyR01MH116039 · NIMH · UNIVERSITY OF GEORGIA · PI MITTAL, VIJAY A, STRAUSS, GREGORY P · 2019 to 2023
$3.1M
1/5 CAPER: Computerized Assessment of ProdromE RiskR01MH120090 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI GOLD, JAMES M. · 2020 to 2024
$2.9M
4/5 CAPER: Computerized assessment of psychosis riskR01MH120092 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2020 to 2024
$2.0M
2/5 CAPER Computerized assessment of psychosis riskR01MH120088 · NIMH · NORTHWESTERN UNIVERSITY · PI MITTAL, VIJAY A · 2020 to 2024
$2.0M
1/3-Community Psychosis Risk Screening: An Instrument Development Study SupplementR01MH112613 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLMAN, LAUREN M · 2017 to 2022
$1.8M
CAPER: Computerized Assessment of Psychosis Risk SupplementR01MH120091 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLMAN, LAUREN M · 2020 to 2024
$1.6M
Administrative Supplement - 3/3: Community Psychology Risk Screening: An Instrument Development StudyR01MH112612 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI PITTS, STEVEN C, SCHIFFMAN, JASON E · 2017 to 2022
$1.3M
2/3 Community psychosis risk screening: An instrument development studyR01MH112545 · NIMH · NORTHWESTERN UNIVERSITY · PI MITTAL, VIJAY A · 2017 to 2021
$1.2M
Mechanisms Underlying Emotion Regulation Abnormalities in Youth at Clinical High-Risk for PsychosisR21MH119438 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2019 to 2020
$415k
NIMH NIH HHS R01 MH112545NIMH NIH HHS R01 MH112612NIMH NIH HHS R01 MH112613NIMH NIH HHS R01 MH116039NIMH NIH HHS R01 MH120088NIMH NIH HHS R01 MH120089NIMH NIH HHS R01 MH120090NIMH NIH HHS R01 MH120091NIMH NIH HHS R01 MH120092NIMH NIH HHS R21 MH119438NIMH NIH HHS U01 MH081988U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 MH1120088
6 · The paper itself

Abstract

Altered visual perception has been observed across all phases of psychotic illness, suggesting that perceptual measures might be useful in identifying people at clinical high risk for psychosis (CHR). In a preliminary study, we found that CHR participants reported perceiving more faces in binarized human portraits on the Mooney Faces Test (MFT). Here, we aimed to replicate these findings and extend understanding of underlying processes and clinical correlates of MFT performance in the Computerized Assessment of Psychosis Risk (CAPR) cohort: CHR (n = 159), help-seeking psychiatric controls (n = 130), and healthy controls (n = 86). The MFT was adapted to include three image conditions (upright, inverted, and scrambled), and included follow-up questions regarding the physical characteristics of the faces that participants reported perceiving, to verify accuracy of perception and assess response bias. The CHR group reported more faces than both control groups in the inverted and scrambled conditions. In addition, the CHR group was as accurate at judging the age and gender of faces as the other groups. Among CHR participants, increased reporting of faces in the inverted condition was significantly correlated with more severe positive symptoms and poorer role functioning. We discuss the findings in terms of multiple perspectives, including changes in perceptual sensitivity, predictive coding, and perceptual organization.

Identifiers

PMID40355455
PMCPMC12069608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.